B. Metzler Seel. Sohn & Co. Holding Ag Arrowhead Pharmaceuticals, Inc. Put Options Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARWR
# of Institutions
294Shares Held
91MCall Options Held
1.28MPut Options Held
503K-
Black Rock Inc. New York, NY15.7MShares$337 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$263 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$191 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$126 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$89 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.28B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...